ALB vs. WST
Compare and contrast key facts about Albemarle Corporation (ALB) and West Pharmaceutical Services, Inc. (WST).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ALB or WST.
Correlation
The correlation between ALB and WST is 0.46, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
ALB vs. WST - Performance Comparison
Loading data...
Key characteristics
ALB:
-0.93
WST:
-0.76
ALB:
-1.37
WST:
-0.83
ALB:
0.84
WST:
0.84
ALB:
-0.62
WST:
-0.73
ALB:
-1.46
WST:
-1.93
ALB:
35.74%
WST:
22.30%
ALB:
58.21%
WST:
54.81%
ALB:
-83.90%
WST:
-59.29%
ALB:
-80.63%
WST:
-55.76%
Fundamentals
ALB:
$7.28B
WST:
$15.51B
ALB:
-$11.12
WST:
$6.36
ALB:
0.99
WST:
3.69
ALB:
1.43
WST:
5.36
ALB:
0.93
WST:
5.88
ALB:
$5.09B
WST:
$2.90B
ALB:
$179.90M
WST:
$1.00B
ALB:
-$811.95M
WST:
$729.50M
Returns By Period
In the year-to-date period, ALB achieves a -28.64% return, which is significantly higher than WST's -36.80% return. Over the past 10 years, ALB has underperformed WST with an annualized return of 0.88%, while WST has yielded a comparatively higher 14.84% annualized return.
ALB
-28.64%
6.43%
-43.00%
-54.10%
1.03%
0.88%
WST
-36.80%
-2.72%
-39.82%
-41.52%
-0.47%
14.84%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ALB vs. WST — Risk-Adjusted Performance Rank
ALB
WST
ALB vs. WST - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Albemarle Corporation (ALB) and West Pharmaceutical Services, Inc. (WST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
ALB vs. WST - Dividend Comparison
ALB's dividend yield for the trailing twelve months is around 2.64%, more than WST's 0.40% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ALB Albemarle Corporation | 2.64% | 1.87% | 1.11% | 0.73% | 0.67% | 1.04% | 2.02% | 1.74% | 1.00% | 1.42% | 2.07% | 1.83% |
WST West Pharmaceutical Services, Inc. | 0.40% | 0.25% | 0.22% | 0.31% | 0.15% | 0.23% | 0.41% | 0.58% | 0.54% | 0.58% | 0.75% | 0.77% |
Drawdowns
ALB vs. WST - Drawdown Comparison
The maximum ALB drawdown since its inception was -83.90%, which is greater than WST's maximum drawdown of -59.29%. Use the drawdown chart below to compare losses from any high point for ALB and WST. For additional features, visit the drawdowns tool.
Loading data...
Volatility
ALB vs. WST - Volatility Comparison
Albemarle Corporation (ALB) has a higher volatility of 12.79% compared to West Pharmaceutical Services, Inc. (WST) at 10.83%. This indicates that ALB's price experiences larger fluctuations and is considered to be riskier than WST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
ALB vs. WST - Financials Comparison
This section allows you to compare key financial metrics between Albemarle Corporation and West Pharmaceutical Services, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ALB vs. WST - Profitability Comparison
ALB - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Albemarle Corporation reported a gross profit of 156.30M and revenue of 1.08B. Therefore, the gross margin over that period was 14.5%.
WST - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, West Pharmaceutical Services, Inc. reported a gross profit of 231.90M and revenue of 698.00M. Therefore, the gross margin over that period was 33.2%.
ALB - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Albemarle Corporation reported an operating income of 19.76M and revenue of 1.08B, resulting in an operating margin of 1.8%.
WST - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, West Pharmaceutical Services, Inc. reported an operating income of 107.00M and revenue of 698.00M, resulting in an operating margin of 15.3%.
ALB - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Albemarle Corporation reported a net income of 41.35M and revenue of 1.08B, resulting in a net margin of 3.8%.
WST - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, West Pharmaceutical Services, Inc. reported a net income of 89.80M and revenue of 698.00M, resulting in a net margin of 12.9%.